Zheng Caiji,Shen Xiaodan,Li Yuji,Pharmaceutical care for patient with schizophrenia combined with pulmonary tuberculosis: a case report[J].SICHUAN MENTAL HEALTH,2022,35(6):577-579
Pharmaceutical care for patient with schizophrenia combined with pulmonary tuberculosis: a case report
DOI:10.11886/scjsws20220507001
English keywords:Schizophrenia  Pulmonary tuberculosis  Clozapine  Rifampicin
Fund projects:广东省高水平临床重点专科(深圳市配套建设经费)资助(项目编号:SZGSP013)
Author NameAffiliationPostcode
Zheng Caiji Shenzhen Mental Health Center/ Shenzhen Kangning Hospital Shenzhen 518020 China 518020
Shen Xiaodan Shenzhen Mental Health Center/ Shenzhen Kangning Hospital Shenzhen 518020 China 518020
Li Yuji* Shenzhen Mental Health Center/ Shenzhen Kangning Hospital Shenzhen 518020 China 518020
Hits:
Download times:
English abstract:
      This paper reported a case of schizophrenia combined with pulmonary tuberculosis treated with clozapine in combination with rifampicin. Due to the induction of hepatic drug enzyme of rifampicin, plasma concentration of clozapine could not reach the effective concentration and the patient still had psychotic symptoms such as persecutory delusion. After discontinuation of rifampicin, plasma concentration of clozapine were in the effective concentration range and the patient's psychiatric symptoms improved. By analysing the therapeutic regimen for the patient with schizophrenia combined with pulmonary tuberculosis, this case suggested a possible interaction between clozapine and rifampin, and provided a reference for the treatment of this type of patients.
View Full Text   View/Add Comment  Download reader
Close